Multiple sclerosis: open trials in Mexico

• NCT06846281

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Mexico City

  Registry updated 2026-10-26

• NCT07161258

  A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

  Trial Treatment · Phase 2 · Hoffmann-La Roche

  Neurociencias Estudios Clinicos S.C., Culiacán · Clinstile, S.A. de C.V., Mexico City

  Registry updated 2026-10-13

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Benito Juárez · Novartis Investigative Site, Chihuahua City · Novartis Investigative Site, Mexico City · Novartis Investigative Site, San Luis Potosí City

  Registry updated 2026-10-13

• NCT06408259

  Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Local Institution - 0078, Mexico City

  Registry updated 2026-09-10

• NCT07521384

  Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

  Research · Healing Hope International

  Stem Solutions, Monterrey

  Registry updated 2026-04-09

• NCT06223074

  Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration

  Trial Treatment · Phase 2 · Universidad Nacional Autonoma de Mexico

  Instituto Nacional de Neurologia y Neurocirugia, Mexico City

  Registry updated 2025-04-03

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error